Romosozumab: all 37 studies that test it

Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• Comparing the Extent to Which Romosozumab (AMG 785) is Made Available in the Body When Administered as a Single SC Injection or as 2 SC InjectionsRecruitingNCT07811999Phase 1
• A Study of Romosozumab in People With Breast Cancer and OsteoporosisRecruitingNCT07776613Phase 2
• Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMDNot yet recruitingNCT07772609Phase 4
• Romosozumab Versus Denosumab In Glucocorticoid-induced Osteoporosis: An Extended Observation Of a Clinical Trial at 6 YearsNot yet recruitingNCT07757373Phase 4
• Romosozumab and Denosumab, Alone or Combined, in Postmenopausal OsteoporosisRecruitingNCT07283887Phase 4
• Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic AmenorrheaRecruitingNCT06533865Phase 3
• The Optimised Use of Romozosumab StudyRecruitingNCT06059222Phase 4
• A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.CompletedNCT06079476Phase 4Results posted
• A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With OsteoporosisCompletedNCT05067335Phase 3Results posted
• Romosozumab in Women With Chronic SCICompletedNCT04708886Phase 2Results posted
• Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis ImperfectaCompletedNCT04545554Phase 1Results posted
• A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for OsteoporosisCompletedNCT03432533Phase 3Results posted
• A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With OsteoporosisCompletedNCT02791516Phase 3Results posted
• A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With OsteoporosisCompletedNCT02186171Phase 3Results posted
• A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With OsteoporosisCompletedNCT02016716Phase 3Results posted
• Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal OsteoporosisCompletedNCT01992159Phase 2Results posted
• Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring HemodialysisCompletedNCT01833754Phase 1Results posted
• A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)CompletedNCT01825785Phase 1Results posted
• An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal WomenCompletedNCT01796301Phase 3Results posted
• Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT01631214Phase 3Results posted
• Transition From Alendronate to Romosozumab (AMG 785)CompletedNCT01588509Phase 1Results posted
• Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With OsteoporosisCompletedNCT01575834Phase 3Results posted
• A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese WomenCompletedNCT01101061Phase 1Results posted
• Study To Assess FRacTure Healing With SclerosTin Antibody - HipCompletedNCT01081678Phase 2Results posted
• A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal WomenCompletedNCT01059435Phase 1Results posted
• A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone MassCompletedNCT00950950Phase 1Results posted
• Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary NailingCompletedNCT00907296Phase 2Results posted
• Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral DensityCompletedNCT00896532Phase 2Results posted
• Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery OutcomesWithdrawnNCT06973109Phase 2
• Romosozumab Versus Denosumab in Glucocorticoid-induced Osteoporosis: an Extended Observation of a Randomized Controlled Trial at 48 MonthsCompletedNCT06472050Phase 4
• Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis ImperfectaActive, not recruitingNCT05972551Phase 3
• A Study of Romosozumab in Women With Multiple Myeloma and OsteoporosisActive, not recruitingNCT05775094Phase 1
• Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCIActive, not recruitingNCT05101018Phase 4
• Romosozumab Use to Build Skeletal IntegrityActive, not recruitingNCT05058976Phase 4
• Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral DensityStatus unknownNCT04597931Phase 4
• Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCICompletedNCT04232657Phase 2
• Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid UsersCompletedNCT04091243Phase 4

← Romosozumab overview